13F Insight
DOSSIER · 13F Holders · Q2 2026Healthcare · Drug Manufacturers - General
LLY

ELI LILLY & CO

4,863 institutions still hold ELI LILLY & CO as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 532457108·Drug Manufacturers - General·4,863 13F holders·last filed Jun 30, 2026
Market cap
$850.0B
13F value held
$616.2B
visible holders
Holders
4,863
filers reporting
Concentration
17.59%
LILLY ENDOWMENT INC #1
top holder share
AI Holders Summary · Q2 2026

LLY registers 4,219 institutional filers with roughly $647 billion in combined 13F value, but the register has a distinctive owner at its apex: Lilly Endowment Inc, founded by Eli Lilly himself, sits at the top with roughly $84 billion—a uniquely concentrated founder-linked position that is almost unheard of in the S&P 500. Beneath it, healthcare-oriented active managers like Capital Research Global Investors and FMR maintain deliberate allocations, while passive vehicles continue their standard broad-market loading.

The passive core follows standard patterns. BlackRock ($61.2 billion), Vanguard Capital Management ($49.1 billion), State Street ($32.8 billion), FMR/Fidelity ($24.2 billion), and Geode ($18.5 billion) form the typical passive-majority top tier. Vanguard Portfolio Management added LLY as a new position this quarter, indicating that an ETF or sleeve rebalance pulled the name into a vehicle that previously did not hold it.

The more informative register read is in the active-manager tier. Capital Research Global Investors extended its position slightly—shares up modestly, signaling an active upgrade. FMR/Fidelity added roughly $613 million in notional value. JPMorgan grew its stake by about $1.8 billion, and Wellington Management added roughly $2.0 billion. These four names are healthcare-oriented or balanced-growth allocators with fundamental research infrastructure dedicated to pharmaceutical and biotech sector analysis; their collective behavior carries more weight than a generic large-cap active manager's LLY position.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LILLY ENDOWMENT INC
CIK 0000316011
$108.4B90.4M100.00%Q2 202602
BlackRock, Inc.
CIK 0002012383
$81.0B67.5M1.20%Q2 202603
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$64.2B53.5M1.37%Q2 202604
PNC FINANCIAL SERVICES GROUP, INC.
CIK 0000713676
$54.9B51.1M32.97%Q4 202505
STATE STREET CORP
CIK 0000093751
$43.4B36.2M1.29%Q2 202606
FMR LLC
CIK 0000315066
$34.1B28.5M1.48%Q2 202607
Capital Research Global Investors
CIK 0001422848
$25.0B20.9M3.49%Q2 202608
Vanguard Portfolio Management
CIK 0002100121· Index
$25.0B20.9M1.13%Q2 202609
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$24.3B20.3M1.29%Q2 202610
MORGAN STANLEY
CIK 0000895421
$19.5B16.2M1.03%Q2 202611
Capital World Investors
CIK 0001422849
$19.1B15.9M2.25%Q2 202612
JPMORGAN CHASE & CO
CIK 0000019617
$15.5B12.6M0.86%Q2 202613
UBS Group AG
CIK 0001610520
$13.8B11.5M1.76%Q2 202614
NORGES BANK
CIK 0001374170· Sovereign
$13.8B11.5M1.37%Q2 202615
BANK OF AMERICA CORP /DE/
CIK 0000070858
$13.5B11.3M0.87%Q2 202616
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$13.2B11.0M2.27%Q2 202617
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO
CIK 0000315032
$12.9B10.8M8.83%Q2 202618
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$12.9B14.0M1.49%Q1 202619
PRIMECAP MANAGEMENT CO/CA/
CIK 0000763212
$11.0B9.2M6.51%Q2 202620
NORTHERN TRUST CORP
CIK 0000073124· Index
$10.6B8.8M1.23%Q2 2026
Page 1 of 244
4843 more holders available. Log in →
Insiders at ELI LILLY & CO
Zakrowski Donald A →Hakim Anat →Luciano Juan R →Sulzberger Gabrielle →Alvarez Ralph →Fyrwald J Erik →Yuffa Ilya →Skovronsky Daniel →